Carter Financial Group’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$979K Buy
2,322
+86
+4% +$34.3K 0.5% 42
2026
Q2
$810K Sell
2,236
-36
-2% -$12.3K 0.42% 49
2026
Q1
$800K Sell
2,272
-55
-2% -$19.6K 0.49% 43
2025
Q4
$762K Buy
2,327
+130
+6% +$41.2K 0.45% 43
2025
Q3
$620K Sell
2,197
-52
-2% -$15.1K 0.37% 48
2025
Q2
$623K Buy
+2,249
New +$637K 0.41% 47

Other funds holding AMGN

Carter Financial Group's AMGN Position: Q3 2026 in Review

Carter Financial Group increased its Amgen (AMGN) stake by 3.8% in Q3 2026, buying an estimated $34.3K and bringing the position to 2,322 shares worth $979K. The position accounts for 0.5% of the portfolio, ranked #42.

Carter Financial Group first reported a position in AMGN in Q2 2025 and has held it in 6 quarters since. 3,276 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Carter Financial Group held 2,322 shares of Amgen worth $979K as of Q3 2026.
  • Carter Financial Group bought 86 Amgen shares in Q3 2026, an estimated $34.3K.
  • Amgen made up 0.5% of Carter Financial Group's portfolio in Q3 2026, its #42 holding.
  • Carter Financial Group first reported a position in Amgen in Q2 2025 and has held it in 6 quarters since.
  • 3,276 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Carter Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.